Registry Data Reassure on JAK Inhibitors' Heart Risks

(MedPage Today) -- Suggestions that rheumatoid arthritis (RA) patients suffer more cardiovascular events when treated with Janus kinase (JAK) inhibitors compared with tumor necrosis factor (TNF) blockers or other biologic drugs were not borne out...